iNtRON Biotechnology, Inc.

iNtRON Biotechnology, Inc. financial statements

iNtRON Biotechnology, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

FY2025

RevenueKRW 5.74BEODHD
Net income−KRW 8.96BEODHD
Cash and equivalentsKRW 27.66BEODHD

iNtRON Biotechnology, Inc. financials on 6ix · iNtRON Biotechnology, Inc. on 6ix